MedPath

Triamterene and Hydrochlorothiazide

Triamterene and Hydrochlorothiazide Tablets USP Rx only

Approved
Approval ID

ab32b7f6-0a2b-426d-b399-358ba1347cc8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 7, 2010

Manufacturers
FDA

State of Florida DOH Central Pharmacy

DUNS: 829348114

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TRIAMTERENE AND HYDROCHLOROTHIAZIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53808-0804
Application NumberANDA071851
Product Classification
M
Marketing Category
C73584
G
Generic Name
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Product Specifications
Route of AdministrationORAL
Effective DateJune 7, 2010
FDA Product Classification

INGREDIENTS (8)

POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQU
Classification: IACT
HYDROCHLOROTHIAZIDEActive
Quantity: 50 mg in 1 1
Code: 0J48LPH2TH
Classification: ACTIB
TRIAMTERENEActive
Quantity: 75 mg in 1 1
Code: WS821Z52LQ
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Triamterene and Hydrochlorothiazide - FDA Drug Approval Details